Therapeutic Potential of Cannabinoids in Glaucoma
Abstract Glaucoma is a leading cause of irreversible blindness worldwide. To date, intraocular pressure (IOP) is the only modifiable risk…
Abstract Glaucoma is a leading cause of irreversible blindness worldwide. To date, intraocular pressure (IOP) is the only modifiable risk…
Abstract Cannabinoids are lipophilic substances derived from Cannabis sativa that can exert a variety of effects in the human body.…
Abstract Delta-9-tetrahydrocannabinol (THC) is the primary psychoactive compound of the cannabis plant and an exogenous ligand of the endocannabinoid system.…
Abstract Despite the wide range of compounds currently available to treat epilepsy, there is still no drug that directly tackles…
Abstract Therapeutic hypothermia is well established as a standard treatment for infants with hypoxic-ischemic (HI) encephalopathy but it is only…
Abstract About twenty molecules sharing 1H-chromeno[3,2-c]pyridine as the scaffold and differing in the degree of saturation of the pyridine ring,…
Abstract Traumatic brain injury is common, and often results in debilitating consequences. Even mild traumatic brain injury leaves approximately 20%…
Abstract There has been an increasing interest in the consumption of halophytes as a healthy food in the last few…
Abstract Cannabidiol (CBD) has numerous pharmacological targets that initiate anti-inflammatory, antioxidative, and antiepileptic properties. These neuroprotective benefits have generated interest…
Abstract The endocannabinoid (EC) system is a complex cell-signaling system that participates in a vast number of biological processes since…